Exact Diagnostics, Fort Worth, Texas, a subsidiary of Bio-Rad Laboratories, Hercules, Calif, has launched the EDX RP positive run control, an unassayed external quality control intended to monitor the performance of clinical respiratory panel tests.
Routine use of the EDX RP positive run control enables laboratories to meet the requirements of their individualized quality control plans, including evaluation of reagent lot changes and new shipments. The control also monitors multiple identical devices and provides an assessment of different personnel and locations.
The EDX RP positive run control includes 22 respiratory analytes that are internally value-assigned using Bio-Rad’s droplet digital polymerase chain reaction (ddPCR) technology. The new multiplex control is a combination of whole, intact virus and bacteria samples that have been heated or chemically inactivated, as well as synthetic RNA transcripts. The control is designed to test the entire process of a molecular assay, including extraction, amplification, and detection. The EDX RP positive run control is the first multianalyte control to target 22 analytes in a single vial, which can save laboratories time and space on their instruments.
For more information, visit Exact Diagnostics.